School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
Department of Pharmacy, Guangdong Second Provincial General Hospital, 510317, PR China.
J Inorg Biochem. 2024 Oct;259:112652. doi: 10.1016/j.jinorgbio.2024.112652. Epub 2024 Jun 26.
Anticancer activity has been extensively studies. In this article, three ligands 2-(6-bromobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (BDIP), 2-(7-methoxybenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (MDIP), 2-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (NDIP) and their iridium(III) complexes: Ir(ppy)(BDIP) (ppy = deprotonated 2-phenylpyridine, 3a), Ir(ppy)(MDIP) (3b) and Ir(ppy)(NDIP) (3c) were synthesized. The cytotoxicity of 3a, 3b, 3c against Huh7, A549, BEL-7402, HepG2, HeLa, and non-cancer NIH3T3 was tested using 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. The results obtained from the MTT test stated clearly that these complexes demonstrated moderate or non-cytotoxicity toward Huh7, BEL-7402, HepG2 and HeLa except A549 cells. To improve the anticancer efficacy, we used white light to irradiate the mixture of cells and complexes for 30 min, the anticancer activity of the complexes was greatly enhanced. Particularly, 3a and 3b exhibited heightened capability to inhibit A549 cells proliferation with IC (half maximal inhibitory concentration) values of 0.7 ± 0.3 μM and 1.8 ± 0.1 μM, respectively. Cellular uptake has shown that 3a and 3b can be accumulated in the cytoplasm. Wound healing and colony forming showed that 3a and 3b significantly hinder the cell migration and growth in the S phase. The complexes open mitochondrial permeability transition pore (MPTP) channel and cause the decrease of membrane potential, release of cytochrome C, activation of caspase 3, and finally lead to apoptosis. In addition, 3a and 3b cause autophagy, increase the lipid peroxidation and lead to ferroptosis. Also, 3a and 3b increase the expression of calreticulin (CRT), high mobility group box 1 (HMGB1), heat shock protein 70 (HSP70), thereby inducing immunogenic cell death.
抗癌活性已得到广泛研究。在本文中,我们合成了三种配体 2-(6-溴苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(BDIP)、2-(7-甲氧基苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(MDIP)、2-(6-硝基苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(NDIP)及其铱(III)配合物:[Ir(ppy)(BDIP)](PF)(ppy=去质子化 2-苯基吡啶,3a)、[Ir(ppy)(MDIP)](PF)(3b)和[Ir(ppy)(NDIP)](PF)(3c)。采用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐(MTT)法检测了 3a、3b、3c 对 Huh7、A549、BEL-7402、HepG2、HeLa 和非癌细胞 NIH3T3 的细胞毒性。MTT 试验结果清楚地表明,这些配合物对 Huh7、BEL-7402、HepG2 和 HeLa (除 A549 细胞外)表现出中等或非细胞毒性。为了提高抗癌效果,我们使用白光照射细胞和配合物的混合物 30 分钟,配合物的抗癌活性大大增强。特别是 3a 和 3b 表现出抑制 A549 细胞增殖的能力,IC(半最大抑制浓度)值分别为 0.7±0.3μM 和 1.8±0.1μM。细胞摄取表明 3a 和 3b 可以在细胞质中积累。划痕愈合和集落形成实验表明,3a 和 3b 可显著抑制细胞迁移和 S 期生长。配合物打开线粒体通透性转换孔(MPTP)通道,导致膜电位降低、细胞色素 C 释放、半胱天冬酶 3 激活,最终导致细胞凋亡。此外,3a 和 3b 引起自噬,增加脂质过氧化,导致铁死亡。同时,3a 和 3b 增加钙网蛋白(CRT)、高迁移率族蛋白 1(HMGB1)和热休克蛋白 70(HSP70)的表达,从而诱导免疫原性细胞死亡。